Drug Discovery · Drug Discovery AI
BenevolentAI: Risk & public record
BenevolentAI: 62 research papers in five years.
Data updated Nov 22, 2026 · Back to the company report
What the registers and the postings say about this employer.
Legal entity active
BENEVOLENTAI LIMITED · find-and-update.company-information.service.gov.uk ↗
Yes
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
BenevolentAI: 62 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
62papers in five years
16kcitations
Computational Drug Discovery Methods
Pharmacology, Toxicology and Pharmaceutics
53 papers
Biomedical Text Mining and Ontologies
Medicine
21 papers
SARS-CoV-2 and COVID-19 Research
Medicine
13 papers
Machine Learning in Materials Science
Materials Science
13 papers
Machine Learning in Healthcare
Computer Science
13 papers
Works most with: University of London, University College London, AstraZeneca (United Kingdom), University of Michigan, Board of the Swiss Federal Institutes of Technology, ETH Zurich
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
